Pfizer Inc. announced that the US Food and Drug Administration (FDA) has approved Abrysvo (Respiratory Syncytial Virus Vaccine), the company’s bivalent RSV prefusion F (RSVpreF) vaccine, for the ...
Pfizer Inc. (PFE) announced that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization ...
Right now, the only RSV vaccine pregnant people can get is the Pfizer vaccine. But there are other vaccines you can get for ...
FDA recalls thousands of antidepressant bottles due to cancer-causing chemical{beacon} Health Care Health Care   The Big ...
As winter approaches, health officials in the Bay Area are strongly encouraging residents to get vaccinated soon against both coronavirus and influenza. This is the ideal time for people to roll up ...
Health officials across Vermont are asking residents to stay safe and prevent the spread of disease by getting updated virus ...
Darzalex will now be available to patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant ...
Previous COVID-19 infection was tied to higher nasal antibody levels after vaccination, and concentrations didn’t differ ...
Americans as young as 18 with a chronic condition can now receive an RSV vaccine after Pfizer snagged expanded FDA approval ...
The Food and Drug Administration (FDA) has approved Abrysvo ® (respiratory syncytial virus [RSV] vaccine) for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by ...
Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...
Abrysvo is the first and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback